This is a StreetInsider.com Premium Only Page

Pacific Bio (PACB) – PRNewswire

Apr 16, 2024 08:05 AM PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance

Mar 27, 2024 08:00 AM Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes

Mar 22, 2024 04:30 PM PacBio Grants Equity Incentive Award to New Employee

Mar 12, 2024 09:05 AM PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions

Feb 26, 2024 04:05 PM PacBio to Present at Upcoming Investor Conferences

Feb 15, 2024 04:05 PM PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 13, 2024 07:00 AM Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch

Feb 5, 2024 09:05 AM PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale

Jan 25, 2024 04:03 PM PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024

Jan 15, 2024 09:05 AM PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions

Jan 11, 2024 10:00 AM TurnCare, Inc. Announces John F. Milligan, PhD, former CEO of Gilead Sciences, joins Board of Directors

Jan 8, 2024 08:00 AM PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively

Dec 27, 2023 04:05 PM PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference

Dec 11, 2023 08:00 AM PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors

Nov 9, 2023 04:10 PM PacBio to Present at Upcoming Investor Conferences

Nov 2, 2023 09:05 AM PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders

Nov 1, 2023 09:05 AM PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible

Oct 31, 2023 09:05 AM PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications

Oct 30, 2023 04:03 PM PacBio Announces Third Quarter 2023 Financial Results

Oct 16, 2023 08:05 AM PacBio Announces Appointment of David Meline to Board of Directors

Oct 12, 2023 04:03 PM PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023

Oct 11, 2023 09:05 AM PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis

Sep 12, 2023 08:00 AM PacBio Announces PacBio Capital

Sep 7, 2023 09:05 AM PacBio Announces Collaboration with Leading Library Preparation Automation Partners

Aug 9, 2023 04:03 PM PacBio to Present at Upcoming Investor Conferences

Aug 4, 2023 07:20 PM PacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Aug 2, 2023 04:06 PM PacBio Announces Second Quarter 2023 Financial Results

Aug 2, 2023 04:04 PM PacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer

Aug 2, 2023 04:02 PM PacBio Begins Commercialization of the Onso Short-Read Sequencing System

Jul 19, 2023 04:05 PM PacBio to Report Second Quarter 2023 Financial Results on August 2, 2023

Jun 28, 2023 07:00 AM PacBio's Revio System Empowers Bioscientia to Scale Long-Read Whole Genome Sequencing and Unravel the Mysteries of Rare Disease

Jun 26, 2023 06:00 AM PacBio Announces a Private Convertible Exchange Transaction of $441 Million Principal Amount of 1.375% Convertible Senior Notes due 2030

Jun 14, 2023 07:00 AM PacBio and Radboud University Medical Center Team Up for New Discoveries in Rare Disease Research

May 30, 2023 09:05 AM PacBio Announces the Appointment of Olga Troyanskaya from Princeton University to the Scientific Advisory Board

May 25, 2023 04:03 PM PacBio to Present at Upcoming Investor Conferences

May 3, 2023 04:05 PM PacBio to Present at BofA Securities 2023 Health Care Conference

May 2, 2023 04:01 PM PacBio Announces Record Revenue in First Quarter 2023

Apr 18, 2023 04:05 PM PacBio to Report First Quarter 2023 Financial Results on May 2, 2023

Apr 5, 2023 09:05 AM PacBio Announces New Nanobind Extraction Kits to Enable High-Throughput Workflows with Revio and Sequel Systems

Mar 28, 2023 09:05 AM PacBio and Corteva Agriscience Enable Groundbreaking Plant and Microbial Long-Read Sequencing Workflow on Revio System

Mar 14, 2023 09:05 AM PacBio Announces a New Informatics Analysis Method for Highly Homologous Genes

Mar 7, 2023 07:05 AM PacBio To Begin Commercial Shipment of Revio Systems

Feb 27, 2023 07:00 AM PacBio to Present at Cowen's 43rd Annual Health Care Conference

Feb 16, 2023 04:02 PM PacBio Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Feb 7, 2023 09:05 AM PacBio to Expand MAS-Seq Technology to 16S rRNA and Bulk RNA-Seq Solutions

Feb 2, 2023 04:02 PM PacBio to Report Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023

Jan 24, 2023 11:18 PM Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock

Jan 24, 2023 04:05 PM Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock

Jan 13, 2023 10:04 AM PacBio Celebrates Nature Methods Naming Long-Read Sequencing "Method of the Year"

Jan 9, 2023 07:05 AM PacBio Announces Record Orders, Including Orders for 76 Revio Systems Received in the Fourth Quarter of 2022